Navigation path
EU research fighting the three major deadly diseases: HIV/AIDS, Malaria and Tuberculosis, EU funding FP7 projects
List of FP7 projects sorted by Acronym
| AnoPopAge | Population age structure and age structure modification via Wolbachia in Anopheles gambiae |
| ARTEMIP | The safety pharmacology of artemisinins when used to reverse pathophysiology of malaria in pregnancy |
| CHAARM | Combined Highly Active Anti-retroviral Microbicides |
| CHAIN | Collaborative HIV and Anti-HIV Drug Resistance Network |
| CRIMALDDI | The Coordination, Rationalisation and Integration of Antimalarial Drug Discovery and Development Initiatives |
| CUT'HIVAC | Cutaneous and Mucosal HIV Vaccination |
| ENAROMaTIC | European Network for Advanced Research on Olfaction for Malaria Transmitting Insect Control |
| ESI-TBVI | Establishment, Strategy and Initial activities of the TuBerculosis Vaccine Initiative : Coordination of European efforts with global research initiatives |
| EUCO-Net | European Network for global cooperation in the field of HIV & TB |
| EuroCoord | European network of HIV/AIDS cohort studies to coordinate at European and International level clinical research on HIV/AIDS |
| EuroNeut-41 | European consortium on NEUTralising antibodies using gp41 |
| Evimalar | Towards the establishment of a permanent European Virtual Institute dedicated to Malaria Research (Evimalar). |
| FAST-XDR-DETECT | Development of a two-approach plate system for the fast and simultaneous detection of MDR and XDR M. tuberculosis |
| HIV-ACE | Targeting assembly of infectious HIV particles |
| HIVIND | The antiretroviral roll out for HIV in India - generating evidence to promote adherence and patient follow-up in the context. |
| HOMITB | Host and mycobacterial molecular dissection of immunity and pathogenesis of tuberculosis |
| iNEF | Inhibiting Nef: a novel drug target for HIV-host interactions |
| INYVAX | Optimisation of the development of Poverty-Related-Diseases (PRD) vaccines by a transversal approach, addressing common gaps and challenges |
| MALACTRES | Multi-drug resistance in malaria under combination therapy: Assessment of specific markers and development of innovative, rapid and simple diagnostics |
| MALSIG | Signalling in life cycle stages of malaria parasites |
| MALVECBLOK | Population biology and molecular genetics of vectorial capacity in Anopheles gambiae: targeting reproductive behaviour and immunity for transmission-refractory interventions |
| MEPHITIS | Targetting protein synthesis in the apicoplast and cytoplasm of plasmodium |
| NANOMAL | Development of a handheld antimalarial drug resistance diagnostic device using nanowire technology |
| NATT | New Approaches to Target Tuberculosis |
| NEWTBVAC | Discovery and preclinical testing of new vaccine candidates for tuberculosis |
| NGIN | Next Generation HIV-1 Immunogens inducing broadly reactive Neutralising antibodies |
| NOstress | Unraveling the molecular mechanism of nitrosative stress resistance in tuberculosis |
| NOVSEC-TB | Novel secretion systems of Mycobacterium tuberculosis and their role in host-pathogen interaction. |
| OPTIMALVAC | Initiative on Optimizing Malaria Vaccine Lab Assays Evaluation |
| PENTA LABNET | Paediatric European Network Treatment AIDS Laboratory Network |
| PRD College | Poverty Related Diseases-College: International Programme on BioMedicine and Development |
| PreMalStruct | Structural analysis of the CSA binding interactions involved during pregnancy associated malaria |
| PregVax | Plasmodium Vivax Infection in Pregnancy |
| REDMAL | Clinical Development of a Pfs48/45-based malaria transmission blocking vaccine |
| StopLATENT-TB | "LATENT TUBERCULOSIS: New tools for the detection and clearance of dormant Mycobacterium tuberculosis." |
| STOPPAM | Strategies TO Prevent Pregnancy-Associated Malaria |
| TB PAN-NET | TB PAN-NET: Pan-European network for study and clinical management of drug resistant tuberculosis. |
| TBsusgent | Sustaining research momentum over the coming decades: mentoring the next generation of researchers for tuberculosis. |
| TB-EURO-GEN | Genetic analysis of the host-pathogen interaction in tuberculosis |
| TB-VIR | Mycobacterium tuberculosis W-Beijing genetic diversity and differential virulence and immune responses |
| THINC | Targeting hiv integration co-factors, targeting cellular proteins during nuclear import or integration of hiv |
| TransMalariaBloc | Blocking Malaria Transmission by Vaccines, Drugs and Immune Mosquitoes: Efficacy Assessment and Targets |
| TM-REST | TM-REST: a new platform for fast molecular detection of MDR and XDR resistant strains of M.tuberculosis and of drug resistant malaria |